Published documents by Hamlet

2009

Proposed dentistry reforms may fail to improve the service, according to the National Audit Office (NAO). The NAO has raised concerns that plans to shake-up NHS dentistry could cause dentists to offer less services to patients. In particular, the watchdog feared that Government changes to the way dentists are paid could directly lead to dentists reducing their commitment to NHS patients....

New NHS IT Chief Appointed, UK - Alan Burns Published on 17/03/2009

UK Health Minister John Hutton today announced that Alan Burns, chief executive of Trent Strategic Health Authority, has been appointed to a new role leading the service implementation of the National Programme for IT into the NHS. The role is a 15 month secondment combining three days a week at the National Programme with his existing SHA role. John Hutton said: \"Engaging clinicians...

BMA calls for more detail on patient choice plans, UK Published on 17/03/2009

Important questions about the government’s patient choice agenda in England remain unanswered, the British Medical Association said today (Thursday 25 November.) Submitting oral evidence to a select committee*, BMA chairman Mr James Johnson said that choice must mean more than exposing NHS providers to competition with the private sector: \"There’s a lot more to choice than deciding...

Private sector contracts are not the solution to the problems of the NHS,... Published on 17/03/2009

BMA Scotland today (Thursday 25 November 2004) expressed concerns over plans by the Scottish Executive to engage with the private sector for health care delivery in Scotland. Dr Peter Terry, chairman of the BMA in Scotland, said: \"Waiting list and activity figures published today reflect some small changes in the delivery of care to patients; a reduction in elective inpatient cases is...

Tanabe to Launch AIDS-related \"ALIXA Tablets 450 mg\" Published on 17/03/2009

Tokyo, Japan, Nov 25, 2004 - (JCN Newswire) - As of November 25, 2004, Tanabe Seiyaku Co. Ltd.( President: Natsuki Hayama)is to launch an AIDS-related drug \"VALIXA Tablets 450 mg\" (Generic Name:Valganciclovir hydrochloride) with indication for treatment of CMV retinitis in AIDS patients. \"VALIXA Tablets 450 mg\" is a pro-drug preparation of ganciclovir, which was developed by F....

Depression treatment boosts employee productivity Published on 17/03/2009

High-quality care for depression can improve productivity at work and lower rates of workplace absenteeism, according to a new report. A two-year program for depressed employees treated at 12 primary care practices nationwide improved productivity at work by an average of 6 percent, or an estimated annual value of $1,491 per depressed full-time employee. The program reduced absenteeism by...

Forensic clock calls time on crime Published on 17/03/2009

A stray hair, or a spatter of blood or saliva, is all it takes to prove that a suspect was at the scene of a crime. But until now, there was no way of knowing when the suspect was there - an element of doubt often exploited by defence lawyers. An ingenious new technique that measures how quickly genetic material breaks down could change that. DNA profiling is now a ubiquitous forensic tool....

Pharmacists want role in drug importation, study shows, USA Published on 17/03/2009

Many community pharmacists are not opposed to importing drugs to lower patients’ costs as long as those drugs are channeled through U.S. pharmacies to ensure safety and efficacy, according to a study by pharmacists at the University of Illinois at Chicago and the University of Michigan. The study will appear in the November/December edition of the Journal of the American Pharmacists...

FDA grants accelerated approval of TYSABRI for treatment of MS Published on 17/03/2009

Phase III Trials at One Year Demonstrate New Level of Efficacy - 66% Reduction in Rate of Relapses Seen in AFFIRM Monotherapy Trial - Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that the U.S. Food and Drug Administration (FDA) has approved TYSABRI (natalizumab), formerly referred to as ANTEGREN, as treatment for relapsing forms of multiple sclerosis (MS)...

Insomnia Poorly Understood By Medical Profession Published on 17/03/2009

A seminar in this week’s issue of THE LANCET (p 1959) outlines the common but poorly understood condition of insomnia, concluding that awareness and assessment of insomnia by family doctors is a priority. Estimates suggest that between 5 and 35% of people experience insomnia. Michael J Sateia (Dartmouth Medical School, USA) and colleagues outline how effective management of insomnia begins...